Open AccessEMPAGLIFLOZIN ADMINISTRATION PREVENTS THE DEVELOPMENT OF MYOCARDIAL FIBROSIS IN ANGIOTENSIN II-DEPENDENT HYPERTENSION
Author(s) -
Maria Colzani,
Cira Di Gioia,
Raffaella Carletti,
Silvia Ippolito,
Federica Barzaghi,
A Stella,
Gianpaolo Zerbini,
Gianluca Perseghin,
Giovanna Castoldi
Publication year - 2019
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000571840.82099.56
Subject(s) - empagliflozin , medicine , sirius red , myocardial fibrosis , fibrosis , angiotensin ii , cellular infiltration , irbesartan , blood pressure , pharmacology , endocrinology , inflammation , diabetes mellitus , type 2 diabetes mellitus